Creative Biolabs

Supports & Resources for Targeted Drug Delivery

Accelerate Your Research and Development!

Welcome to the Creative Biolabs Support & Resource Center, your dedicated portal for accessing advanced technical information and direct scientific assistance related to targeted delivery systems. This page is meticulously organized to empower researchers and partners by providing immediate access to comprehensive documentation, including detailed SOPs, technical data sheets, and peer-reviewed studies. Below, you can find entry points to seamlessly transition between our core service offerings (Delivery Systems, Ligands, and Applications) and a direct channel to connect with our R&D specialists for complex, project-specific technical queries.

Targeted Delivery System

Explore our full portfolio of advanced drug delivery platforms. This includes next-generation liposomes, lipid nanoparticles (LNPs), polymeric micelles, and extracellular vesicles (exosomes). We tailor these systems to ensure optimal payload encapsulation, superior systemic stability, and controlled release kinetics for various therapeutics.

Distributed under Freepik License, from Freepik.

Targeting Ligand

Review our ligand discovery and conjugation services. We specialize in identifying and engineering high-affinity ligands, such as single-domain antibodies and peptides, that precisely guide drug carriers to disease-specific biomarkers, maximizing therapeutic efficacy while significantly reducing unwanted systemic side effects.

Distributed under Freepik License, from Freepik.

Application

See the therapeutic power of targeted delivery in action. Our platforms are validated for crucial applications, including potent oncology treatments, delivery of mRNA and plasmids for gene therapies, and effective solutions against infectious diseases. We provide end-to-end support from preclinical validation to clinical scale-up.

Distributed under Freepik License, from Freepik.

Resources

Access the complete archive of Creative Biolabs resources. This index contains general corporate news, press releases, comprehensive reports on industry trends, and high-level regulatory updates relevant to the biopharmaceutical landscape. Use this index to stay informed on the broader biotech field.

Why We Can Offer: Comprehensive Targeted Delivery Solutions

Creative Biolabs is a global leader in precision nanomedicine, offering end-to-end solutions from initial target validation to final manufacturing. We provide both ready-to-use products and fully customized development services to accelerate your therapeutic pipeline across oncology, gene therapy, and infectious disease applications.

Drug Delivery Systems & Products

  • Advanced Nanocarriers: Liposomes, Exosomes (Extracellular Vesicles), and Lipid Nanoparticles (LNPs).
  • Polymeric & Peptide Systems: Polymeric Micelles, Microspheres, and Cell-Penetrating Peptides (CPPs).
  • Custom Payload Encapsulation: Expertise in delivering small molecules, proteins, mRNA, siRNA, and gene editing components.
  • Alternative Carriers: Fc Fusion Proteins, Albumin-based carriers, Graphene Oxide, and Hyaluronic Acid systems.

Targeting & Bioconjugation Services

Experience the Creative Biolabs Advantage - Get a Quote Today

Online Inquiry

Customer Review

Creatibe Biolabs' custom LNP was the only solution that successfully delivered our CRISPR-Cas9 payload across the blood-brain barrier with high efficiency and low toxicity.”

Dr. Evelyn Reed

Postdoctoral Researcher, Leading University

Our siRNA candidate was failing due to off-target toxicity, but Creatibe Biolabs' team rapidly redesigned our LNP using their modular platform, rescuing our preclinical program.”

Ben Carter

Project Manager

Achieving cytosolic delivery of our protein degrader with Creatibe Biolabs' exosome platform was the key to unlocking our candidate's full therapeutic potential.”

Dr. Kenji Tanaka

Principal Scientist, Large Pharma Corp

Our oncology drug's efficacy was limited by poor tumor accumulation. Creatibe Biolabs' peptide-conjugated liposomes provided the precise targeting we needed, dramatically increasing the drug's therapeutic index.”

Dr. Clara Schmidt

Senior Scientist, Oncology Innovations Inc.

We required a delivery system that would only release its payload in the tumor's acidic microenvironment. Creatibe Biolabs' pH-responsive liposomes performed flawlessly, minimizing systemic exposure.”

David Chen

Formulation Scientist

Outstanding expertise in antibody engineering.The team's attention to detail and innovative approaches have sianificantly accelerated our development timeline.

Sarah L.

Senior Research Scientist

Contact us for more information Get free consultations